'Halftime Report' Traders Share Their View On Zogenix, Spotify And Marvell

On CNBC's "Fast Money Halftime Report," Stephen Weiss said he likes Zogenix, Inc. ZGNX. He bought some on Tuesday. He believes its drug for epilepsy still works and he expects the stock to recover.

Trending Investment Opportunities

Arrived
Buy shares of homes and vacation rentals for as little as $100.
WiserAdvisor
Get matched with a trusted, local financial advisor for free.
Point.com
Tap into your home's equity to consolidate debt or fund a renovation.
Robinhood
Move your 401k to Robinhood and get a 3% match on deposits.

Jon Najarian thinks Spotify Technology SA SPOT is cheap at its current price level. He added that the company has an antitrust complaint against Apple Inc. AAPL, which will have an impact on the stock.

Pete Najarian advised a viewer to roll up call options in Marvell Technology Group Ltd. MRVL. He would choose the 26.50 strike, because he noticed some activity in that strike. He owns the calls in the name.